Back

Number of inflamed coronary vessels in prediction of cardiac death and MACE among patients undergoing routine CCTA: the Oxford Risk Factors And Non-Invasive Imaging (ORFAN) Study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Coronary computed tomography angiograms for diagnosis and risk stratification Noninvasive Diagnostic Methods ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Kenneth Chan

John Radcliffe Hospital, Oxford (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Impact of coronary CT angiography on the hospital outcome among patients admitted with AMI undergoing revascularization procedures in theUS
Doctor S. Shoar (Largo, US)
Abstract Slides Video
Presentation thumbnail
Low density lipoprotein cholesterol and cardiovascular disease risk in patients with absence of coronary artery calcification: a multicenter cohort study
Doctor M. Andersen (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Association between high versus low cardiovascular risk in individuals with corresponding unexpected absent versus severe subclinical coronary atherosclerosis, a nationwide, multicenter study
Doctor M. Johansson (Malmo, SE)
Abstract Slides Video
Presentation thumbnail
Real world data after the implementation of coronary computed tomography angiography in Swedish primary care to rule out coronary artery disease, a cross-sectional study based on pre-test probability
Mr E. Stertman (Linkoping, SE)
Abstract Slides Video
Presentation thumbnail
Assessment of surgical revascularization completeness with quantitative myocardial blood flow distribution derived from CCTA in severe coronary artery disease
Professor P. Serruys (Galway, IE)
Abstract Slides Video

Access the full session

Session thumbnail
Coronary computed tomography angiograms for diagnosis and risk stratification
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources